Streptococcus pneumoniae Nasopharyngeal Carriage in Children Attending Day-Care Centers in the Central Region of Portugal, In the Era of 7-Valent Pneumococcal Conjugate Vaccine

被引:23
作者
Rodrigues, Fernanda [1 ]
Nunes, Sonia [2 ]
Sa-Leao, Raquel [2 ,3 ]
Goncalves, Guilherme [4 ]
Lemos, Luis [1 ]
de Lencastre, Herminia [2 ,5 ]
机构
[1] Pediat Hosp Coimbra, Infect Dis Unit, Coimbra, Portugal
[2] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, Oeiras, Portugal
[3] Univ Lisbon, Ctr Math & Fundamental Applicat, P-1699 Lisbon, Portugal
[4] Univ Porto, Abel Salazar Inst Biomed Sci ICBAS, P-4100 Oporto, Portugal
[5] Rockefeller Univ, New York, NY 10021 USA
关键词
DRUG-RESISTANCE; HEALTHY-CHILDREN; ANTIBIOTIC USE; RISK-FACTORS; DISEASE; COLONIZATION; EFFICACY; SEROTYPES; IMMUNOGENICITY; IMMUNIZATION;
D O I
10.1089/mdr.2009.0043
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The 7-valent pneumococcal conjugate vaccine became available in Portugal in 2001. Although not included in the national immunization program, vaccination coverage is high (over 60%). We studied for the first time the rates of nasopharyngeal (NP) carriage of pneumococci, antibiotic resistance patterns and serotypes among children attending day-care centers (DCCs) in Coimbra, a city in the Central Region of Portugal. Between January and February 2007, a cross-sectional study was conducted among children aged 6 months to 6 years attending eight DCCs. NP swabs were obtained from 507 children: 76.7% had received at least one dose of 7-valent pneumococcal conjugate vaccine and 64.3% were age-appropriately vaccinated. The global pneumococcal carriage rate was 61.3%. Colonization proportions varied with age and number of children attending each DCC. Serotyping revealed that 20.7% of the pneumococci were vaccine types (VTs), 70.8% were non-VTs, and 8.5% were nontypeable. Serotype 19F was the second most frequent serotype being detected in 10.5% of the samples. While global NP carriage was not associated with vaccination status, non-VTs were predominant among vaccinated children, who had significantly lower prevalence of VT. Of all isolates, 15.7% had penicillin minimum inhibitory concentrations that ranged between 0.12 and 2 mu g/ml. The proportion of resistant strains was significantly higher among VT and unvaccinated children. In conclusion, the rates of vaccination and prevalence of pneumococcal NP were high. Rates of antimicrobial resistance were similar to those found in studies conducted in Oeiras and Lisbon. This study is a platform for future surveillance activities.
引用
收藏
页码:269 / 277
页数:9
相关论文
共 46 条
  • [1] Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine
    Aguiar, S. I.
    Serrano, I.
    Pinto, F. R.
    Melo-Cristino, J.
    Ramirez, M.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (09) : 835 - 843
  • [2] Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
    Black, S
    Shinefield, H
    Fireman, B
    Lewis, E
    Ray, P
    Hansen, JR
    Elvin, L
    Ensor, KM
    Hackell, J
    Siber, G
    Malinoski, F
    Madore, D
    Chang, I
    Kohberger, R
    Watson, W
    Austrian, R
    Edwards, K
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) : 187 - 195
  • [3] Streptococcus pneumoniae colonisation:: the key to pneumococcal disease
    Bogaert, D
    de Groot, R
    Hermans, PWM
    [J]. LANCET INFECTIOUS DISEASES, 2004, 4 (03) : 144 - 154
  • [4] Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes
    Carrico, J. A.
    Silva-Costa, C.
    Melo-Cristino, J.
    Pinto, F. R.
    de Lencastre, H.
    Almeida, J. S.
    Ramirez, M.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (07) : 2524 - 2532
  • [5] *CLIN LAB STAND I, 2008, M2A9 CLIN LAB STAN S, V28
  • [6] Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
    Cutts, FT
    Zaman, SMA
    Enwere, G
    Jaffar, S
    Levine, OS
    Okoko, JB
    Oluwalana, C
    Vaughan, A
    Obaro, SK
    Leach, A
    McAdam, KP
    Biney, E
    Saaka, M
    Onwuchekwa, U
    Yallop, F
    Pierce, NF
    Greenwood, BM
    Adegbola, RA
    [J]. LANCET, 2005, 365 (9465) : 1139 - 1146
  • [7] Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus
    Dagan, R
    Givon-Lavi, N
    Fraser, D
    Lipsitch, M
    Siber, GR
    Kohberger, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (03) : 367 - 376
  • [8] Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees
    Dagan, R
    Sikuler-Cohen, M
    Zamir, O
    Janco, J
    Givon-Lavi, N
    Fraser, D
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (10) : 951 - 958
  • [9] Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
    Dagan, R
    Melamed, R
    Muallem, M
    Piglansky, L
    Greenberg, D
    Abramson, O
    Mendelman, PM
    Bohidar, N
    Yagupsky, P
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) : 1271 - 1278
  • [10] De Queiros Laurinda, 2004, Acta Med Port, V17, P49